Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

Human hair follicle cells can be turned into stem cells similar to embryonic stem cells.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

DNA methylation changes are linked to hair growth cycles in goats.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

IGF-1 affects hair loss and could be a potential treatment.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

The hepatitis B vaccine did not cause hair loss in the tested mice.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Researchers found four genes that could help diagnose severe alopecia areata early.